ACE2 and COVID-19: The novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, interacts with angiotensin-converting enzyme 2 (ACE2), a cellular binding site expressed in the heart, kidney and pulmonary alveolar type II cells.